市場調査レポート

商品コード

1789491

モノクローナル抗体治療薬市場：供給源別、用途別、流通チャネル別、地域別

Monoclonal Antibody Therapeutics Market, By Source, by Application, By Distribution Channel, and By Region

出版日: 2025年07月30日
発行: Coherent Market Insights
ページ情報: 英文 335 Pages
納期: 2～3営業日

カスタマイズ可能

価格

Unprintable PDF & Excel (Single User License)

USD 4,500 669,285円

レポートPDF・Excel Databookを1名のみがご利用頂けるライセンスです。テキスト等のコピー、印刷はできません。

PDF & Excel (Multi User License - Up to 7 Users)

USD 7,000 1,041,110円

レポートPDF・Excel Databookを7名までご利用頂けるライセンスです。テキスト等のコピー＆ペースト、印刷は可能です。印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Corporate User License)

USD 10,000 1,487,300円

レポートPDF・Excel Databookを同一企業およびその子会社のすべての方にご利用頂けるライセンスです。テキスト等のコピー＆ペースト、印刷は可能です。印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=148.73円

全表示
概要
目次

概要

サンプル依頼リストに入れる

モノクローナル抗体治療薬市場は、2025年には2,939億2,000万米ドルと推定され、2032年には6,783億1,000万米ドルに達すると予測され、2025年から2032年にかけてCAGR12.69％で成長すると予測されています。

レポート範囲		レポート詳細
基準年	2024	2025年の市場規模	2,939億2,000万米ドル
実績データ	2020年から2024年まで	予測期間	2025年から2032年
予測期間：2025年～2032年CAGR：	12.69%	2032年の価値予測	6,783億1,000万米ドル

免疫システムは、細菌やウイルスなどの病気を引き起こす病原体を検出し、破壊する複雑なチームから構成されています。同様に、このシステムは、がん細胞などの損傷を受けた細胞を排除することもあります。免疫系が侵入者を見つけて破壊する方法のひとつに抗体があります。モノクローナル抗体療法は、特定の細胞やタンパク質に単特異的に結合するモノクローナル抗体（mAbs）を用いた免疫療法の一種です。この治療の目的は、患者の免疫系を刺激してそれらの細胞を攻撃させることです。ここ数年、CTLA-4、PD-1、PD-L1などの免疫チェックポイントに作用する、独自の作用機序を持つさまざまなモノクローナル抗体が承認されています。各メーカーは、がんから希少疾患まで様々な疾患を治療するため、様々なクラスに属する薬剤の開発に注力しています。モノクローナル抗体と化学療法剤との併用は、さまざまながんを治療する有力な選択肢になりつつあります。また、2020年にはCOVID-19治療用のモノクローナル抗体治療薬の開発が活発化します。

市場力学

同市場では、主要規制当局による製品ポートフォリオ拡大の認可など、成長戦略の採用が増加しており、予測期間中の市場成長の原動力になると予想されます。例えば、2022年2月、米国食品医薬品局（FDA）は、オミクロン変異体に対する活性を保持するCOVID-19治療用の製薬会社Lilly社製の新規モノクローナル抗体bebtelovimabの緊急使用認可（EUA）を発行しました。

本調査の主な特徴

本レポートでは、世界のモノクローナル抗体治療薬市場を詳細に分析し、2024年を基準年とした2025～2032年の市場規模（10億米ドル）と年間平均成長率（CAGR%）を掲載しています。
また、さまざまなセグメントにわたる潜在的な収益機会を明らかにし、この市場の魅力的な投資提案のマトリックスについて説明しています。
また市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
世界のモノクローナル抗体治療薬市場における主要企業プロファイルを、企業ハイライト、製品ポートフォリオ、主要ハイライト、業績、戦略などのパラメータに基づいて掲載しています。
本レポートからの洞察により、マーケティング担当者や企業の経営陣は、将来の製品上市、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことができます。
世界のモノクローナル抗体治療薬市場レポートは、投資家、サプライヤー、製品メーカー、販売業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者を対象としています。
利害関係者は、世界のモノクローナル抗体治療薬市場の分析に使用される様々な戦略マトリックスを通じて、意思決定が容易になります。

Pfizer Inc.
Novartis AG
Bayer AG
Sanofi
F. Hoffmann-La Roche Ltd.
Eli Lilly and Company
Merck KGaA
GSK plc
AbbVie Inc.
Bristol-Myers Squibb Company
Regeneron Pharmaceuticals Inc.
AstraZeneca
AbCellera Biologics Inc.
Molecular Depot LLC
DAIICHI SANKYO COMPANY, LIMITED
Abbott
Biogen
Thermo Fisher Scientific, Inc.
Cell Signaling Technology, Inc.
Intas Pharmaceuticals Ltd.
Avantor, Inc.
UCB S.A.
Merus N.V.
GENEXTGENOMICS.COM
Biogenuix

第9章セクション

調査手法
出版社について

Product Code: CMI2403

Monoclonal Antibody Therapeutics Market is estimated to be valued at USD 293.92 Bn in 2025 and is expected to reach USD 678.31 Bn by 2032, growing at a compound annual growth rate (CAGR) of 12.69% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 293.92 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	12.69%	2032 Value Projection:	USD 678.31 Bn

The immune system is made up of a complex team of players that detect and destroy disease-causing agents, such as bacteria and viruses. Similarly, this system may eliminate damaged cells, such as cancer cells. One way the immune system finds and destroys invaders is with antibodies. Monoclonal antibody therapy is a form of immunotherapy that uses monoclonal antibodies (mAbs) to bind monospecifically to certain cells or proteins. The objective is that this treatment will stimulate the patient's immune system to attack those cells. Different monoclonal antibodies with unique mechanism of actions have been approved over the past few years, which work on immune checkpoints such as CTLA-4, PD-1, and PD-L1. Manufacturers are focusing on developing drugs belonging to various classes in order to treat variety of diseases ranging from cancer to rare diseases. Monoclonal antibody coupled with chemotherapy agents is becoming a viable treatment option to treat various cancers. Also, there was a boost in the development of monoclonal antibody therapeutics for the treatment of COVID-19 in the year 2020

Market Dynamics

Increasing adoption of growth strategies, such as authorization by key regulatory authorities in the market to expand their product portfolio, is expected to drive the market growth over the forecast period. For instance, in February 2022, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for a new monoclonal antibody, bebtelovimab manufactured by Lilly, a pharmaceutical company for the treatment of COVID-19 that retains activity against the omicron variant.

Key features of the study

This report provides in-depth analysis of the global monoclonal antibody therapeutics market, and provides market size (USD Bn) and Compound Annual Growth Rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global monoclonal antibody therapeutics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study are Pfizer Inc., Novartis AG, Bayer AG, Sanofi, F. Hoffmann-La Roche Ltd, Eli Lilly and Company, Merck KGaA, GSK plc., AbbVie Inc., Bristol-Myers Squibb Company, Regeneron Pharmaceuticals Inc., AstraZeneca, AbCellera Biologics Inc., Molecular Depot LLC, DAIICHI SANKYO COMPANY, LIMITED., Abbott, Biogen, Thermo Fisher Scientific, Inc., Cell Signaling Technology, Inc, Intas Pharmaceuticals Ltd., Avantor Inc., UCB S.A., Merus N.V., GENEXTGENOMICS.COM, Biogenuix.
Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global monoclonal antibody therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global monoclonal antibody therapeutics market.

Market Segmentation

Global Monoclonal Antibody Therapeutics Market, By Source
- Human
- Chimeric
- Murine
- Humanized
Global Monoclonal Antibody Therapeutics Market, By Application
- Cancer
- Autoimmune Disease
- Hematological Disease
- Infectious Disease
- Others
Global Monoclonal Antibody Therapeutics Market, By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Global Monoclonal Antibody Therapeutics Market, By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Pfizer Inc.
- Novartis AG
- Bayer AG
- Sanofi
- Hoffmann-La Roche Ltd.
- Eli Lilly and Company
- Merck KGaA
- GSK plc
- AbbVie Inc.
- Bristol-Myers Squibb Company
- Regeneron Pharmaceuticals Inc.
- AstraZeneca
- AbCellera Biologics Inc.
- Molecular Depot LLC
- DAIICHI SANKYO COMPANY LIMITED
- Abbott
- Biogen
- Thermo Fisher Scientific, Inc.
- Cell Signaling Technology, Inc.
- Intas Pharmaceuticals Ltd.
- Avantor Inc.
- UCB S.A.
- Merus N.V.
- GENEXTGENOMICS.COM
- Biogenuix

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Source
- Market Snapshot, By Application
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Key Highlights
Product Launch
Technological Advancements
PEST Analysis
Regulatory Scenario
Mergers and Acquisitions

4. Global Monoclonal Antibody Therapeutics Market, By Source, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Human
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Chimeric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Murine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Humanized
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Monoclonal Antibody Therapeutics Market, By Application, 2020 - 2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Autoimmune Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Hematological Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Infectious Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Monoclonal Antibody Therapeutics Market, By Distribution Channel, 2020 - 2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segments Trends
Hospital Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Retail Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Online Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Monoclonal Antibody Therapeutics Market, By Region, 2020 - 2032, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Regions, 2021-2032
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Bayer AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Sanofi
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
F. Hoffmann-La Roche Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Merck KGaA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
GSK plc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
AbbVie Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Bristol-Myers Squibb Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Regeneron Pharmaceuticals Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
AstraZeneca
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
AbCellera Biologics Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Molecular Depot LLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
DAIICHI SANKYO COMPANY, LIMITED
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Abbott
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Biogen
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Thermo Fisher Scientific, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Cell Signaling Technology, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Intas Pharmaceuticals Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Avantor, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
UCB S.A.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Merus N.V.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
GENEXTGENOMICS.COM
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Biogenuix
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies

9. Section

Research Methodology
About Us

モノクローナル抗体治療薬市場：供給源別、用途別、流通チャネル別、地域別

Monoclonal Antibody Therapeutics Market, By Source, by Application, By Distribution Channel, and By Region

市場力学

目次

第1章調査の目的と前提条件

第2章市場の展望

第3章市場力学、規制、動向分析

第4章世界のモノクローナル抗体治療薬市場、供給源別、2020年～2032年

第5章世界のモノクローナル抗体治療薬市場、用途別、2020年～2032年

第6章世界のモノクローナル抗体治療薬市場、流通チャネル別、2020年～2032年

第7章世界のモノクローナル抗体治療薬市場、地域別、2020年～2032年

第8章競合情勢

第9章セクション

Market Dynamics

Market Segmentation

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Monoclonal Antibody Therapeutics Market, By Source, 2020-2032, (USD Bn)

5. Global Monoclonal Antibody Therapeutics Market, By Application, 2020 - 2032, (USD Bn)

6. Global Monoclonal Antibody Therapeutics Market, By Distribution Channel, 2020 - 2032, (USD Bn)

7. Global Monoclonal Antibody Therapeutics Market, By Region, 2020 - 2032, (USD Bn)

8. Competitive Landscape

9. Section

モノクローナル抗体治療薬市場：供給源別、用途別、流通チャネル別、地域別

Monoclonal Antibody Therapeutics Market, By Source, by Application, By Distribution Channel, and By Region

市場力学

目次

第1章 調査の目的と前提条件

第2章 市場の展望

第3章 市場力学、規制、動向分析

第4章 世界のモノクローナル抗体治療薬市場、供給源別、2020年～2032年

第5章 世界のモノクローナル抗体治療薬市場、用途別、2020年～2032年

第6章 世界のモノクローナル抗体治療薬市場、流通チャネル別、2020年～2032年

第7章 世界のモノクローナル抗体治療薬市場、地域別、2020年～2032年

第8章 競合情勢

第9章 セクション

Market Dynamics

Market Segmentation

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Monoclonal Antibody Therapeutics Market, By Source, 2020-2032, (USD Bn)

5. Global Monoclonal Antibody Therapeutics Market, By Application, 2020 - 2032, (USD Bn)

6. Global Monoclonal Antibody Therapeutics Market, By Distribution Channel, 2020 - 2032, (USD Bn)

7. Global Monoclonal Antibody Therapeutics Market, By Region, 2020 - 2032, (USD Bn)

8. Competitive Landscape

9. Section

第1章調査の目的と前提条件

第2章市場の展望

第3章市場力学、規制、動向分析

第4章世界のモノクローナル抗体治療薬市場、供給源別、2020年～2032年

第5章世界のモノクローナル抗体治療薬市場、用途別、2020年～2032年

第6章世界のモノクローナル抗体治療薬市場、流通チャネル別、2020年～2032年

第7章世界のモノクローナル抗体治療薬市場、地域別、2020年～2032年

第8章競合情勢

第9章セクション